RE: Reformulation!On October 02, 2009 the company reached an agreement with the FDA on a protocol for the Phase 3 trial. On February 18, 2010 they got agreement from the UK. In March BT said that the trial would start in thee weeks. In May we're told that the delay is due to a problem shipping Reolysin and the trial will start by the END of the second quarter. Am I wrong, or is there something not right with this picture. At this rate we'll be into 2011 before the trial starts.
We are rather not getting the facts, or there is an element of incompetence in this management team. And I don't think these people are stupid. Secretive perhaps, but not stupid.